000			01499 a2200385 4500
005			20250513203634.0
264		0	_c20000420
008			200004s 0 0 eng d
022			_a0003-4967
024	7		_a10.1136/ard.59.3.196 _2doi
040			_aNLM _beng _cNLM
100	1		_aJoosten, L A
245	0	0	_aBlockade of endogenous interleukin 12 results in suppression of murine streptococcal cell wall arthritis by enhancement of interleukin 10 and interleukin 1Ra. _h[electronic resource]
260			_bAnnals of the rheumatic diseases _cMar 2000
300			_a196-205 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAcute Disease
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aArthritis, Infectious _ximmunology
650	0	4	_aCell Wall _ximmunology
650	0	4	_aInterleukin 1 Receptor Antagonist Protein
650	0	4	_aInterleukin-10 _xbiosynthesis
650	0	4	_aInterleukin-12 _xantagonists & inhibitors
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aReverse Transcriptase Polymerase Chain Reaction
650	0	4	_aSialoglycoproteins _xbiosynthesis
650	0	4	_aStreptococcus pyogenes _ximmunology
700	1		_aHelsen, M M
700	1		_avan Den Berg, W B
773	0		_tAnnals of the rheumatic diseases _gvol. 59 _gno. 3 _gp. 196-205
856	4	0	_uhttps://doi.org/10.1136/ard.59.3.196 _zAvailable from publisher's website
999			_c10654507 _d10654507